CRISPR patent row not over yet, say lawyers


Although the Patent Trial and Appeal Board (PTAB) gave a win to The Broad Institute of Harvard and MIT in the CRISPR patent conflict against the University of California (UC), Berkeley and the University of Vienna, lawyers say the dispute may still not be resolved.

UC Berkeley, CRISPR, PTAB, The Broad Institute, Harvard, MIT, genome editing, CRISPR-Cas9, Federal Circuit, patent